#Paysign
Paysign Is A Leader In #Fintech #Healthcare #Payments With Durable Profitable Growth

The company excels in 2 primary sectors: plasma payment processing and pharma patient affordability, both offering significant growth and high margins.

seekingalpha.com/article/4738...

#FinServ #Banking #PayTech
Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth
Paysign has two industry-leading businesses with accelerating growth and profit inflection underway. See why PAYS stock is a Buy.
seekingalpha.com
November 20, 2024 at 7:44 PM
Feed: "Benzinga - Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals"
By: Benzinga Insights on Friday, March 27, 2026
Here's How Much $100 Invested In PaySign 10 Years Ago Would Be Worth Today
Importance Rank:  1 read more
www.benzinga.com
March 28, 2026 at 1:18 AM
Looking to call Visa as a cardholder? CSL Plasma gave us a paysign Visa for going in to donate plasma; are we saying to go sell your life juice? Nah, but it’s a funny coincidence that’s the card we thought we couldn’t call
August 11, 2025 at 4:42 AM
📄 #PAYS 10-Q — what changed
MD&A now says: "Specific forward-looking statements made herein include: our belief that we do not anticipate any losses with respect to accounts with balances exceeding federally insured limits; our expected lease obligations for subsequent years; our belief that our pl
FormDelta — Insider Trading Alerts
What Paysign, Inc. changed in their own words, quarter over quarter.
www.formdelta.com
August 14, 2026 at 9:00 PM
Paysign (NASDAQ:PAYS) Announces Earnings Results

Paysign (NASDAQ:PAYS – Get Free Report) announced its earnings results on Wednesday. The company reported $0.11 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.05, FiscalAI reports. The company had revenue of $28.25…
Paysign (NASDAQ:PAYS) Announces Earnings Results
Paysign (NASDAQ:PAYS – Get Free Report) announced its earnings results on Wednesday. The company reported $0.11 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.05, FiscalAI reports. The company had revenue of $28.25 million during the quarter, compared to analyst estimates of $26.36 million. Paysign had a net margin of [...]
news-area.com
August 8, 2026 at 5:29 AM
Paysign CEO’su Mark Newcomer 1,78 milyon dolarlık hisse sattı
Paysign CEO’su Mark Newcomer 1,78 milyon dolarlık hisse sattı
yonetimrotasi.com.tr
August 8, 2026 at 1:44 AM
Paysign CEO’su Mark Newcomer 468.985 dolar değerinde hisse sattı
Paysign CEO’su Mark Newcomer 468.985 dolar değerinde hisse sattı
yonetimrotasi.com.tr
August 1, 2026 at 12:43 AM
Paysign yönetim kurulu üyesi Bruce Mina 141.950 dolar değerinde hisse sattı
Paysign yönetim kurulu üyesi Bruce Mina 141.950 dolar değerinde hisse sattı
yonetimrotasi.com.tr
August 1, 2026 at 12:43 AM
Paysign is an interesting company. It has tools to enable the pharmaceutical industry to bypass horrible "Copay Accumulators" which benefit the insurance company and its PBM. Read more about that at www.drugchannels.net/2025/06/movi...
June 18, 2025 at 2:43 PM
Paysign股票一年涨幅突破113%,未来上涨空间几何?

https://qian.cx/posts/8C0083F4-D299-47BE-A4DF-884D0D1FC265
October 18, 2025 at 3:53 AM
Paysign股价目标上调至8美元,市场前景看好迎来新机遇

https://qian.cx/posts/D033552A-C349-4231-96DF-4A4F47EF3993
September 3, 2025 at 4:47 PM
Paysign Targets 30%–35% Revenue Growth for 2026: Paysign set a 30%–35% revenue-growth target for 2026 (Seeking Alpha, Mar 25, 2026), a range roughly double small-cap payments consensus and raising… 👈 Read full analysis #Paysign #RevenueGrowth #SmallCapStocks #InvestmentInsights #FinancialTargets
Paysign Targets 30%–35% Revenue Growth for 2026
Paysign set a 30%–35% revenue-growth target for 2026 (Seeking Alpha, Mar 25, 2026), a range roughly double small-cap payments consensus and raising execution scrutiny.
dlvr.it
March 25, 2026 at 9:14 AM